Navigation Links
OHSU discovery may someday lead to prevention and treatment of sudden infant death syndrome
Date:2/16/2012

Researchers at Oregon Health & Science University have discovered that brain cells commonly thought to play a supporting role actually are critically important for the growth of brainstem neurons responsible for cardiorespiratory control. The discovery has profound implications for the prevention and treatment of SIDS (Sudden Infant Death Syndrome), the leading cause of death in children aged one month to one year.

The new discovery is published online in Neuroscience: http://www.sciencedirect.com/science/article/pii/S0306452212000358

In their study, the OHSU team looked at glial cells, non-neuronal cells of the brain, and found that they very potently regulate growth of nerve cells in the brainstem. In fact, the glial cells actually inhibit the growth of brainstem neurons and may be as important for establishing neuronal networks as neurotrophic factors, a family of proteins essential for brain growth and survival. The OHSU study is the first to find that glial cells inhibit nerve cell growth.

"Previous research has shown that a common feature of the brains of SIDS babies is a dramatically increased number of glial cells," said Agnieszka Balkowiec, M.D., Ph.D., principal investigator and associate professor of integrative biosciences in the OHSU School of Dentistry. "Based on the results of our new study, the increase in glial cells in SIDS babies could be the cause of a compromised growth of brainstem neurons that control the cardiorespiratory function and, ultimately, cause death."

The new study also shows that glial cells direct the growth of brainstem neurons caused by BDNF (Brain-Derived Neurotrophic Factor), another molecule found by the Balkowiec lab to play an important role in cardiorespiratory control.

"Our study shows that the picture is more complex than we had previously thought," said Balkowiec. "A better understanding of interactions between BDNF and glial cells could play a significant role in the development of treatment for SIDS, high blood pressure, and other disorders with a deficient cardiorespiratory control."


'/>"/>

Contact: Sydney Clevenger
clevenge@ohsu.edu
Oregon Health & Science University
Source:Eurekalert

Related biology news :

1. Notre Dame researchers report fundamental malaria discovery
2. Discovery of plant nourishing gene brings hope for increased crop seed yield and food security
3. Discovery could help stem smoking-related diseases
4. Georgetown researchers lead discovery expected to significantly change biomedical research
5. New horned dinosaur announced nearly 100 years after discovery
6. Researchers awarded $3.2 million from NIH to pioneer advanced biomolecule discovery technology
7. UGA discovery changes how scientists think about plant cell wall formation
8. Discovery of therapeutic peptides affecting mitochondria
9. ORNL fundamental discovery casts enzymes in new light
10. Scripps research team achieves critical step to opening elusive class of compounds to drug discovery
11. Discovery of new gene could improve efficiency of molecular factories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2017)... 2017  RSA Conference -- RSA, a Dell Technologies ... to enhance fraud detection and investigation across digital ... Fraud & Risk Intelligence Suite. The new platform ... insights from internal and external sources as well ... customers from targeted cybercrime attacks. "Fraudsters ...
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... NEW YORK , Feb. 8, 2017 /PRNewswire/ ... an individual,s voice to match it against a ... voice such as pitch, cadence, and tone are ... systems require minimal hardware installation, as most PCs ... remotely for different transactions. Voice recognition biometrics are ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... ANGELES , Feb. 16, 2017   ... ), a clinical-stage biotechnology company developing first-in-class biological ... announced that it has elected to terminate its ... natriuretic peptide receptor agonists, including Cenderitide. ... strategic move as we prioritize our efforts to ...
(Date:2/16/2017)... SAN DIEGO , Feb. 16, 2017 /PRNewswire/ ... and innovative products to treat a variety of ... $5 million Series 1a financing and entered into ... Bank (SVB).  Dermata intends to use the capital ... of making major advancements in the treatment of ...
(Date:2/16/2017)... , Feb. 16, 2017  Rhythm, ... rare genetic deficiencies that result in life-threatening ... a $41 million mezzanine round of financing ... OrbiMed, MPM Capital, New Enterprise Associates, Pfizer ... undisclosed public healthcare investment fund. Rhythm will ...
(Date:2/15/2017)... ... 15, 2017 , ... Park Systems , a leader in Atomic Force ... that drastically boosts productivity with single click reliable nanoscale images, is now available on ... up and taking the image once done manually by the operator producing high quality ...
Breaking Biology Technology: